|
|
|
|
|
|
|
|
"Clearly, as we develop more accurate estimates of risks associated with specific mutations, personalized screening methods and intervals will need to be further clarified among those with LS. Although it appears that the overall risk for CRC among those with LS may be lower than previously thought, there are likely to be specific mutations that confer a higher risk and require more intensive screening protocols."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.